About UCSF Search UCSF UCSF Medical Center

Vivian K. Weinberg, PhD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
weinberg_vivian

Principal Statistician, Biostatistics and Computational Biology Core, UCSF Helen Diller Family Comprehensive Cancer Center

weinberg@cc.ucsf.edu

Phone: (415) 502-5472 (voice)
Box 0127, UCSF
San Francisco, CA 94143-0127


Education

University of Rochester, Rochester, NY, B.A., 1972, Mathematics
SUNY at Buffalo, Buffalo, NY, M.A., 1973, Statistics
Yale University, New Haven, CT, Ph.D., 1993, Biostatistics


Professional Experience

  • 1973-76
    Research Assistant, Department of Public Health, Cornell University Medical College, NY
  • 1976-82
    Research Associate, Cancer & Leukemia Group B, Dept. of Neoplastic Diseases, Mt Sinai Hosp, NY, NY
  • 1986-90
    Biostatistician, Dept. of Oncology, Montefiore Med Ctr-Albert Einstein Cancer Ctr, Bronx, NY
  • 1992-97
    Principal Biostatistician, General & Pediatric Clinical Research Centers, UCSF
  • 1997-present
    Principal Biostatistician, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA

Selected Publications

  • Freeman A. I., Weinberg V., Brecher M. L., Jones B., Glicksman A. S., Sinks L. F., Weil M., Pleuss H., Hananian J., Burgert, Jr., E. O., Gilchrist G. S., Necheles T., Harris M., Kung F., Patterson R. B., Maurer H., Leventhal B., Chevalier L., Forman E., Holland J. F.: Comparison of Intermediate-Dose Methotrexate with Cranial Irradiation for the Post-Induction Treatment of Acute Lymphocytic Leukemia in Children. New England Journal of Medicine. 1983, 308:477-484.
  • Tormey D. C., Weinberg V. E., Holland J. F., Weiss R. B., Glidewell O. J., Perloff M., Falkson G., Falkson H. C., Henry P. H., Leone L. A., Rafla S., Ginsberg S. J., Silver R. T., Blom J., Carey R. W., Schein P. S., Lesnick G. J.: A Randomized Trial of Five and Three Drug Chemotherapy and Chemoimmunotherapy in Women with Operable Node Positive Breast Cancer. Journal of Clinical Oncology. 1983, 1(2)8-145.
  • Perry M. C., Kardinal C. G., Weinberg V., Ginsberg S., Hughes A., Wood W.: Chemotherapy with Cyclophosphamide, Adriamycin and 5-Fluorouracil Compared to Chemotherapy Plus Hormonal Therapy with Tamoxifen in the Treatment of Advanced Breast Cancer: An Interim Analysis. Journal of Steroid Biochemistry. 23:1135-1140, 1985.
  • Aisner J., Weinberg V., Perloff M., Weiss R., Perry M., Korzun A., Ginsberg S., Holland J. F.: Chemotherapy Versus Chemoimmunotherapy (CAF V CAFVP V CMF Each ± MER) for Metastatic Carcinoma of the Breast: A CALGB Study. Journal of Clinical Oncology. 1987, 5(10):1523-1533.
  • Wadler S., Schwartz E., Goldman M., Lyver A., Rader H., Zimmerman M., Itri L., Weinberg V., Wiernik P. H.: Fluorouracil and Recombinant Alpha-2-Interferon: An Active Regimen Against Advanced Colorectal Carcinoma. Journal of Clinical Oncology. 1989, 7(12):1769-1775.
  • Wiernik P.H., Dutcher J.P., Paietta E., Gucalp R., Markus S., Weinberg V., Azar C., Garl S., Benson L.: Long-Term Follow-up of Treatment and Potential Cure of Adult Acute Lymphocytic Leukemia with MOAD:a NonAnthracycline Containing Regimen. Leukemia 1993,7(8):1236-1241.
  • Roychowdhury D.F., Tseng Jr. A., Fu K.K., Weinberg V., Weidner N.: New Prognostic Factors in Nasopharyngeal Carcinoma: Tumor Angiogenesis and C-erbB2 Expression. Cancer. 1996, 77(8), 1419-1426.
  • Matthay KK., DeSantes K., Hasegawa B., Huberty J., Hattner R.S., Ablin A., Reynolds P., Seeger R.C., Weinberg V.K., Price D.: Phase I Dose Escalation of 131I-Metaiodobenzylguanidine with Autologous Bone Marrow Support in Refractory Neuroblastoma. Journal of Clinical Oncology, 1998, 16(1), 229-236.
  • Seaward S.A., Weinberg V., Lewis P., Leigh B., Phillips T.L., Roach III M.: Improved Freedom from PSA Failure with Whole Pelvic Irradiation for High Risk Prostate Cancer. IJROBP, 1998, 42(5), 1055-1062.
  • Nudell D.M., Grossfeld G.D., Weinberg V.K., Roach III M, Carroll P.R.: Radiotherapy Following Radical Prostatectomy: Treatment Outcomes and Patterns of Failure. Urology, 1999, 54(6), 1049-57.
  • Speight JL, Shinohara K, Pickett B, Weinberg VK, Hsu CJ, Roach III M: Prostate Volume Change After Radioactive Seed Implantation: Possible Benefit of Improved Dose Volume Histogram with Perioperative Steroid. IJROBP, 2000,48(5) 1461-1467.
  • Meng MV, Grossfeld GD, Williams GH, Dilworth S, Stoeber K, Mulley TW, Weinberg V, Carroll PR, Tlsty TD: Minichromosome maintenance protein 2 expression in prostate: characterization and association with outcome after therapy for cancer. Clinical Cancer Research 2001 Sep;7(9):2712-8.
  • Kobayashi A, Darragh T, Herndier B, Anastos K, Minkoff H, Cohen M, Young M, Levine A, Grant LH, Hyun W, Weinberg V, Greenblatt R, Smith-McCune K. Lymphoid follicles are generated in high-grade cervical dysplasia and have differing characteristics depending on HIV status. Am J Pathol 2002, 160:151-164.
  • Rauen KA, Sudilovsky D, Le JL, Chew KL, Hann B, Weinberg V, Schmitt LD,McCormick F. Expression of the Coxsackie adenovirus receptor in normal prostate and in primary and metastatic prostate carcinoma: potential relevance to gene therapy. Cancer Res. 2002 Jul 1;62(13):3812-8.
  • Rini B, Weinberg V, Bok R, Small E: PSA Kinetics as a Measure of the Biologic Effect of GM-CSF in Patients with Serologic Progression of Prostate Cancer. J Clin Oncol. 2003 Jan 1;21(1):99-105.
  • Roach III M, Weinberg V, McLaughlin PW, Grossfeld G, Sandler HM: Serum Prostate Specific Antigen (PSA) and Survival Following External Beam Radiotherapy for Carcinoma of the Prostate, M.D., Urology 2003 April 4, 730-735.
  • Takamiya, R., Weinberg, V., Young, C.D., McLaughlin, P., Sandler, H., Roach, M.: A Zero PSA Slope in Post-Treatment Prostate Specific Antigen Supports Cure of Patients with Long Term Follow-up After External Beam Radiation Therapy for Localized Prostate Cancer. IJROBP 2003 Jul 15;56(4):1073-8.
  • DeWitt K, Roach M, Weinberg V, McLaughlin PW and Sandler HM: What Does Post-Radiotherapy PSA Nadir Tell Us About Freedom-From PSA Failure and Progression-Free Survival in Patients with Low and Intermediate Risk Localized Prostate Cancer? Urology 2003 Sept 62(3):492-6.
  • Paris PL, Andaya A, Fridlyand J, Jain AN, Weinberg V, Kowbel D, Brebner JH, Simko J, Watson JE, Volik S, Albertson DG, Pinkel D, Alers JC, van der Kwast TH, Vissers KJ, Schroder FH, Wildhagen MF, Febbo PG, Chinnaiyan AM, Pienta KJ, Carroll PR, Rubin MA, Collins C, van Dekken H: Whole genome scanning identifies genotypes associated with recurrence and metastasis in prostate tumors. Hum Mol Genet. 2004 Jul 1;13(13):1303-13.
  • Rini BI, Weinberg V, Shaw V, Scott J, Bok R, Park JW, Small EJ: Time to disease progression to evaluate a novel protein kinase C inhibitor, UCN-01, in renal cell carcinoma. Cancer. 2004 Jul 1;101(1):90-5.
  • Oh WK, Kantoff PW, Weinberg V, Jones G, Rini BI, Derynck MK, Bok R, Smith MR, Bubley GJ, Rosen RT, DiPaola RS, Small EJ: Prospective, Multicenter, Randomized Phase II Trial of the Herbal Supplement, PC-SPES, and Diethylstilbestrol in Patients With Androgen-Independent Prostate Cancer. J Clin Oncol. 2004 Sep 15;22(18):3705-12.
  • Kobayashi A, Greenblatt RM, Anastos K, Minkoff H, Massad LS, Young M, Levine AM, Darragh TM, Weinberg V, Smith-McCune KK. Functional Attributes of Mucosal Immunity in Cervical Intraepithelial Neoplasia and Effects of HIV Infection. Cancer Res. 2004 Sep 15;64(18):6766-6774.
  • Jung JA, Coakley FV, Vigneron DB, Swanson MG, Qayyum A, Weinberg V, Jones KD, Carroll PR, Kurhanewicz J: Prostate depiction at endorectal MR spectroscopic imaging: investigation of a standardized evaluation system. Radiology. 2004 Dec;233(3):701-8.
  • Hsu IC, Lessard E, Weinberg V, Pouliot J: Comparison of inverse planning simulated annealing and geometrical optimization for prostate high-dose-rate brachytherapy. Brachytherapy. 2004;3(3):147-52.
  • Paris P, Weinberg V, Simko J, Andaya A, Albo G, Rubin MA, Carroll PR and Collins C: Preliminary Evaluation of Prostate Cancer Metastatic Risk Biomarkers. Accepted by The International Journal of Biological Markers.
  • Rini BI, Weinberg V, Dunlap S, Elchinoff A, Yu N, Bok R, Simko J, and Small EJ. Maximal COX-2 Immunostaining and Clinical Response to Celecoxib and Interferon Alpha Therapy in Metastatic Renal Cell Carcinoma. Cancer. 2006 Feb 1;106(3):566-75.
  • Jorge Garcia, Weinberg V, Small EJ. Prior Estrogen Therapy as a Predictor of Response to Subsequent Estramustine-Based Chemotherapy in Patients with Androgen-Independent Prostate Cancer. Clinical Prostate Cancer. 2005 Sep;4(2):113-7.